Autopsy report · NCT04402242

Impact of NOL Index Intraoperative Guided Remifentanil Analgesia

“The very slow pace of enrolment and the difficulty in identifying a third study centre.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 2 years 3 months before it stopped.
• 90 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Hopital Foch

Sponsor type

University, hospital or other

Conditions

Abdominal Surgery

Interventions

Bispectral index; Bispectral index + NOL index

Participants

90

Sites

3

Countries

France

Trials that died the same way

• IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer
  “it's too slow to enroll suitable patients into this study” (65% match in meaning)
• Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
  “for difficulty to enroll patients in the study” (65% match in meaning)
• Pharmacokinetics and Safety of Moxifloxacin
  “slow enrolment of patients and new insights” (64% match in meaning)
• Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder
  “difficulty in the enrolment” (64% match in meaning)
• Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI
  “Technical and organisational issues at the center, leading to inability to enrol study participants” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.